Evaluation and Treatment of Patients with Major Depressive Disorder: Are We Considering All the Options?

Publication
Article
Pharmacy TimesAugust 2012 Pain Awareness
Volume 78
Issue 8

This activity is supported by an educational grant from Mylan Specialty, LP.

Evaluation and Treatment of Patients with Major Depressive Disorder: Are We Considering All the Options?

Megan Maroney, PharmD

Clinical Assistant ProfessorErnest Mario School of PharmacyRutgers UniversityPiscataway, New JerseyClinical Psychiatric PharmacistMonmouth Medical CenterLong Branch, New Jersey

Megan Maroney, PharmD, has no financial relationships with commercial interests to disclose related to this activity.

Pharmacy Times Office of Continuing Professional Education Planning Staff

Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD, have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.

Pharmacy Times Editorial Staff

Jennifer Whartenby and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.

The peer reviewer of this activity has no relevant financial relationships with commercial interests to disclose related to this activity.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Review the pathophysiology and epidemiology of major depressive disorder (MDD), atypical depression, and treatment-resistant depression.
  • Address challenges of treating depression, including safety concerns (eg, adverse effects, drug—food interactions), noncompliance, relapse, and inadequate response to antidepressant therapy.
  • Discuss current and emerging antidepressant treatments, including strategies used for typical and treatment-resistant depression.
  • Formulate counseling strategies to improve patient outcomes in depression.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: August 10, 2012

Expiration date: August 10, 2014

Estimated time to complete activity: 2 hours

Fee: This lesson is free online

Click here to view this activity.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.